Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes

S.A.M.E.G. Timmermans; J.G.M.C. Damoiseaux; A. Werion; C.P. Reutelingsperger; J. Morelle; P. van Paassen

doi:10.1016/j.ekir.2021.01.034

Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes

S.A.M.E.G. Timmermans, J.G.M.C. Damoiseaux, A. Werion, C.P. Reutelingsperger, J. Morelle, P. van Paassen^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	1099-1109
Number of pages	11
Journal	Kidney International Reports
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/j.ekir.2021.01.034
Publication status	Published - 1 Apr 2021

Keywords

atypical hemolytic uremic syndrome
complement
eculizumab
hypertensive emergency
kidney transplantation
pregnancy
thrombotic microangiopathy
HEMOLYTIC-UREMIC SYNDROME
FACTOR-I
INHIBITOR ECULIZUMAB
ACTIVATION
VARIANTS
AHUS
MUTATIONS
DISEASE
PREGNANCY
DEFECTS

Access to Document

10.1016/j.ekir.2021.01.034Licence: CC BY

Cite this

Timmermans, S. A. M. E. G., Damoiseaux, J. G. M. C., Werion, A., Reutelingsperger, C. P., Morelle, J., & van Paassen, P. (2021). Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes. Kidney International Reports, 6(4), 1099-1109. https://doi.org/10.1016/j.ekir.2021.01.034

@article{e151645822e04b309760b0a145800543,

title = "Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes",

keywords = "atypical hemolytic uremic syndrome, complement, eculizumab, hypertensive emergency, kidney transplantation, pregnancy, thrombotic microangiopathy, HEMOLYTIC-UREMIC SYNDROME, FACTOR-I, INHIBITOR ECULIZUMAB, ACTIVATION, VARIANTS, AHUS, MUTATIONS, DISEASE, PREGNANCY, DEFECTS",

author = "S.A.M.E.G. Timmermans and J.G.M.C. Damoiseaux and A. Werion and C.P. Reutelingsperger and J. Morelle and {van Paassen}, P.",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.ekir.2021.01.034",

language = "English",

volume = "6",

pages = "1099--1109",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Science",

number = "4",

}

Timmermans, SAMEG , Damoiseaux, JGMC, Werion, A, Reutelingsperger, CP, Morelle, J & van Paassen, P 2021, 'Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes', Kidney International Reports, vol. 6, no. 4, pp. 1099-1109. https://doi.org/10.1016/j.ekir.2021.01.034

Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes. / Timmermans, S.A.M.E.G.; Damoiseaux, J.G.M.C.; Werion, A.; Reutelingsperger, C.P.; Morelle, J.; van Paassen, P.

In: Kidney International Reports, Vol. 6, No. 4, 01.04.2021, p. 1099-1109.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes

AU - Timmermans, S.A.M.E.G.

AU - Damoiseaux, J.G.M.C.

AU - Werion, A.

AU - Reutelingsperger, C.P.

AU - Morelle, J.

AU - van Paassen, P.

PY - 2021/4/1

Y1 - 2021/4/1

KW - atypical hemolytic uremic syndrome

KW - complement

KW - eculizumab

KW - hypertensive emergency

KW - kidney transplantation

KW - pregnancy

KW - thrombotic microangiopathy

KW - HEMOLYTIC-UREMIC SYNDROME

KW - FACTOR-I

KW - INHIBITOR ECULIZUMAB

KW - ACTIVATION

KW - VARIANTS

KW - AHUS

KW - MUTATIONS

KW - DISEASE

KW - PREGNANCY

KW - DEFECTS

U2 - 10.1016/j.ekir.2021.01.034

DO - 10.1016/j.ekir.2021.01.034

M3 - Article

C2 - 33912760

VL - 6

SP - 1099

EP - 1109

JO - Kidney International Reports

JF - Kidney International Reports

SN - 2468-0249

IS - 4

ER -